Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis-Reference-Cited by-同舟云学术

Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis

Published:2020-12-19 Issue:2 Volume:23 Page:352-362
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Desai Niraj¹²^ORCID,Wilson Brigid³,Bond Michael⁴,Conant Alexander²,Rahman Mahboob¹²³

Affiliation:

1. Division of Nephrology Louis Stokes Cleveland VA Medical Center Cleveland OH USA

2. Case Western Reserve University School of Medicine Cleveland OH USA

3. Geriatric Research, Education, and Clinical Centers Louis Stokes Cleveland VA Medical Center Cleveland OH USA

4. Division of Nephrology University Hospitals Cleveland Medical Center Cleveland USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.14091

Reference37 articles.

1. Centers for Disease Control and Prevention.Chronic Kidney Disease Surveillance System—United States. [cited 2016 Sept 22].https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q372. Accessed May 28 2018.

2. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

3. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States;Muntner P;J Am Soc Nephrol,2002

4. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization

5. Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the impact of aspirin on patients with chronic kidney disease; a systematic review and meta-analysis;Journal of Renal Injury Prevention;2024-06-24

2. A Thorough Literature Review of the Potential Benefits and Drawbacks of Long-Term Aspirin Use for the Primary Prevention of Cardiovascular Disease;Cardiology in Review;2024-05-24

3. Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis;American Journal of Cardiovascular Drugs;2024-02-01

4. Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE;American Heart Journal;2023-10

5. Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis;Current Vascular Pharmacology;2023-05-30